Liraglutide The injectable GLP-1 analogue, liraglutide (Victoza), is FDA approved for once-daily subcutaneous administration in combination with diet and exercise for the treatment of patients with T2DM
CJC-1295 Overview Top Benefits: Skin elasticity, muscle growth, fat loss, and improved recovery Form: Lyophilized (freeze-dried) powder form, reconstituted with bacteriostatic water before injection Max Time Used: 8 to 12 weeks Average Cost: $52 Side Effects : May include injection site reactions, water retention, and potential impact on insulin sensitivity
Spatially resolved mapping of cells associated with human complex traits
A 20mg vial provides approximately 1.67 weekly doses at 12mg, meaning you need about 3 vials for every 5 weeks of maintenance
GLP-1 medications have been a hot topic lately, its likely youve even seen a commercial on TV